Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04496804
Other study ID # 300005111
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2, 2020
Est. completion date November 3, 2021

Study information

Verified date September 2021
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Multiple sclerosis [MS] is a prevalent neurological disease that is the leading cause of irreversible neurological disability among young women and the second leading cause of disability among young men in the United States. This disease results in the progressive loss of walking mobility and substantial worsening of cognition, symptoms, and quality of life over time. There is evidence that physical activity is beneficially associated with aerobic fitness and brain structure and function in persons with MS. Nevertheless, this population is strikingly sedentary and physically inactive. This highlights a vital opportunity to improve aerobic fitness and brain health by developing behavioral interventions that increase physical activity. To that end, this project is a Phase-II randomized control trial for examining the efficacy of a behavioral intervention that is based on social-cognitive theory and delivered through the Internet for increasing physical activity and, secondarily, improving aerobic fitness and brain structure and function in persons with MS.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date November 3, 2021
Est. primary completion date November 3, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - diagnosis of multiple sclerosis - relapse free in the last 30 days - being non-active defined as not engaging in regular activity (30 minutes accumulated per day) on more than 2 days of the week during the previous 6 months - ambulate without assistance - low risk for contraindications for MRI Exclusion Criteria: - moderate or high risk for undertaking strenuous or maximal exercise

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Behavioral Intervention for Physical Activity in MS (BIPAMS)
A behavioral intervention that involves an Internet website and one-on-one video coaching calls for increasing physical activity in people with MS.
Wellness for MS (WellMS)
A behavioral intervention that involves an Internet website and one-on-one video coaching calls for increasing wellness in people with MS.

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Minutes of moderate to vigorous physical activity - Baseline Activity monitors are Actigraph accelerometers that participants will wear on an elastic belt around their waist for 7 days. These activity monitors measure how frequently and how much an individual moves. Assessment will be conducted before the intervention
Primary Minutes of moderate to vigorous physical activity - Post intervention Activity monitors are Actigraph accelerometers that participants will wear on an elastic belt around their waist for 7 days. These activity monitors measure how frequently and how much an individual moves. Assessment will be conducted immediately after the intervention
Secondary cardiorespiratory fitness; oxygen consumption during exercise - baseline A graded exercise test on a treadmill. Participants will walk at a quick pace on the treadmill and the incline will increase every 2 minutes until the participant is no longer able to keep pace with the treadmill. Assessment will be conducted before the intervention
Secondary cardiorespiratory fitness; oxygen consumption during exercise - post intervention A graded exercise test on a treadmill. Participants will walk at a quick pace on the treadmill and the incline will increase every 2 minutes until the participant is no longer able to keep pace with the treadmill. Assessment will be conducted immediately after the intervention
Secondary distance walked - baseline The six-minute walk test will be used to measure walking endurance. The test involves walking for 6 minutes without stopping. Assessment will be conducted before the intervention
Secondary distance walked - post-intervention The six-minute walk test will be used to measure walking endurance. The test involves walking for 6 minutes without stopping. Assessment will be conducted immediately after the intervention
Secondary information processing speed; cognitive function - baseline The symbol digit modalities test will be used to measure information processing speed. The test involves matching numbers to symbols. Assessment will be conducted before the intervention
Secondary information processing speed; cognitive function - post intervention The symbol digit modalities test will be used to measure information processing speed. The test involves matching numbers to symbols. Assessment will be conducted immediately after the intervention
Secondary volume of subcortical grey matter brain structures - baseline An MRI will be conducted to measure brain structure. Assessment will be conducted before the intervention
Secondary volume of subcortical grey matter brain structures - post intervention An MRI will be conducted to measure brain structure. Assessment will be conducted immediately after the intervention
Secondary resting state functional brain connectivity - baseline An MRI will be conducted to measure brain function. Assessment will be conducted before the intervention
Secondary resting state functional brain connectivity - post intervention An MRI will be conducted to measure brain function. Assessment will be conducted immediately after the intervention
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4